Glenmark Life Sciences IPO: Opening on 27th July; 35% shares allocated for retail investors – Know price band, issue size, lot size and MORE
Glenmark Life Sciences will utilise the net proceeds from the fresh issue towards “payment of outstanding purchase consideration to the Promoter for the spin-off of the API business from the Promoter into the Company pursuant to the Business Purchase Agreement dated October 9, 2018,” the company said in the release
IPO Glenmark Life Sciences Limited (GLS) will open on 27 July 2021 (Tuesday) and will end on 29 July (Thursday). Source: Website